Revvity, Inc. (FRA:PKN)

Market Cap	9.06B
Revenue (ttm)	2.39B
Net Income (ttm)	243.42M
Shares Out	n/a
EPS (ttm)	2.02
PE Ratio	37.21
Forward PE	17.34
Dividend	0.25 (0.31%)
Ex-Dividend Date	Jul 18, 2025

Volume	n/a
Average Volume	116
Open	81.36
Previous Close	82.00
Day's Range	81.36 - 82.50
52-Week Range	76.82 - 121.05
Beta	n/a
RSI	42.14
Earnings Date	Jul 31, 2025

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company’s Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for tes...

• Industry: Laboratory Analytical Instruments
• Founded: 1937
• Employees: 11,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PKN

Financial Performance

In 2024, Revvity's revenue was $2.76 billion, an increase of 0.16% compared to the previous year's $2.75 billion. Earnings were $270.39 million, a decrease of -60.99%.

Financial numbers in USD